In this insightful piece by Ben Feller, a father’s simple moment of joy with his son sparks a powerful call to reshape the way we talk about modern fatherhood.
INSIGHTS FROM
THE TEAM
Our take on the most, and least,
effective communication
Lee Carter recently joined host Jason Chaffetz on the Jason in the House podcast for a conversation on “The Importance of Looking Beyond the Data.”
Lee Carter joined CNN’s Jake Tapper for a colorful panel discussion on topics ranging from Trump’s “big beautiful bill” and Democrats’ failure to come up with a better solution… to the new Trump “TACO” acronym and more. Some fun and always-insightful analysis from Lee!
As the Trump administration fights over the future of its tariffs in the courts, companies are anxiously considering how to deal with this massive shift in U.S. trade policy. Tariffs have already increased costs for many businesses, and they threaten the ability of some companies to survive. Many companies are asking: what’s the right language and framing to talk about tariffs in a way that protects our business without antagonizing Washington? Michael Maslansky offers some sound advice for how to respond while mitigating the risk.
How do you connect with a critical audience or constituency when you don’t have a message that resonates with them? Michael Maslansky addressed this question on NewsNation with Leland Vittert, for an interesting conversation on how the Democratic party has failed to reach and connect with young white men.
In this episode of Hearsay, Lee Carter is joined by partners Keith Yazmir and Katie Cronen to unpack why communicating effectively—especially in industries like pharma—is harder than ever.
President Trump’s executive order on pharmaceutical pricing is a wake-up call. For pharma companies, the question is not whether or not to react—but how. And how pharma companies react will have a big impact on where this debate ends. Reframe the narrative right and they have a unique opportunity to shift the conversation and become champions of both innovation and accessibility. Here’s thoughtful guidance for a constructive response.
With the administration’s increased focus on pharma and healthcare, companies across these sectors need to be ready to engage and communicate their side of the story. Many companies are looking for guidance in their messaging response to the healthcare executive order and the broader policy landscape, from tariffs to MAHA initiatives. Should your company address this directly or let the industry associations take it on? Lee Carter sheds some much-needed light on this question, with the warning: if you don’t tell your story, someone else will. And it will not be to your advantage.
It’s a chaotic time in America. Trust is shattered. People are angry. From DEI and tariffs, to rising prices, excessive profits, and broken promises, people on the left and the right believe our system is broken—and that dramatic change needs to happen. And business is getting the brunt of it. Companies need to respond to shift the conversation in their favor. In this eye-opening piece, Lee Carter shares how it’s time for a new way forward, with actionable insights to help you thrive in this new environment.